Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II
- PMID: 18025783
- DOI: 10.1159/000111082
Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II
Abstract
Background/aims: The aim of this study was to determine the consistency of neuropsychiatric subsyndromes of the Neuropsychiatric Inventory across several clinical and demographic subgroups (e.g. dementia subtypes, dementia severity, medication use, age and gender) in a large sample of outpatients with dementia.
Methods: Cross-sectional data of 2,808 patients with dementia from 12 centres from the European Alzheimer's Disease Consortium were collected. Principal component analysis was used for factor analysis. Subanalyses were performed for dementia subtypes, dementia severity, medication use, age and gender.
Results: The results showed the relatively consistent presence of the 4 neuropsychiatric subsyndromes 'hyperactivity', 'psychosis', 'affective symptoms' and 'apathy' across the subanalyses. The factor structure was not dependent on dementia subtypes, age and gender but was dependent on dementia severity and cholinesterase use. The factors hyperactivity and affective symptoms were present in all subanalyses, but the presence of the factors apathy and psychosis was dependent on use of cholinesterase inhibitors and dementia severity, respectively.
Conclusion: The present study provided evidence of the relative consistency of neuropsychiatric subsyndromes across dementia subtypes, age and gender, thereby stressing the importance of thinking about neuropsychiatric subsyndromes instead of separate symptoms. However, the subsyndromes apathy and psychosis were dependent on use of cholinesterase inhibitors and dementia severity.
(c) 2007 S. Karger AG, Basel.
Similar articles
-
Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.Dement Geriatr Cogn Disord. 2007;24(6):457-63. doi: 10.1159/000110738. Epub 2007 Nov 7. Dement Geriatr Cogn Disord. 2007. PMID: 17986816 Review.
-
Behavioral and psychological subsyndromes in Alzheimer's disease using the Neuropsychiatric Inventory.Int J Geriatr Psychiatry. 2013 Aug;28(8):795-803. doi: 10.1002/gps.3904. Epub 2012 Nov 12. Int J Geriatr Psychiatry. 2013. PMID: 23147419 Review.
-
Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes.Int Psychogeriatr. 2010 Jun;22(4):629-40. doi: 10.1017/S1041610210000281. Epub 2010 Apr 6. Int Psychogeriatr. 2010. PMID: 20367890
-
Neuropsychiatric symptoms and subsyndromes in patients with different stages of dementia in primary care follow-up (NeDEM project): a cross-sectional study.BMC Geriatr. 2022 Jan 22;22(1):71. doi: 10.1186/s12877-022-02762-9. BMC Geriatr. 2022. PMID: 35065615 Free PMC article.
-
Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory.Dement Geriatr Cogn Disord. 2003;15(2):99-105. doi: 10.1159/000067972. Dement Geriatr Cogn Disord. 2003. PMID: 12566599
Cited by
-
Use of anti-dementia drugs in home care and residential care and associations with neuropsychiatric symptoms: a cross-sectional study.BMC Geriatr. 2015 Aug 13;15:100. doi: 10.1186/s12877-015-0102-4. BMC Geriatr. 2015. PMID: 26268660 Free PMC article.
-
Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.Am J Geriatr Psychiatry. 2013 Jul;21(7):607-22. doi: 10.1016/j.jagp.2012.10.027. Epub 2013 Apr 18. Am J Geriatr Psychiatry. 2013. PMID: 23602309 Free PMC article.
-
Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients.Dement Geriatr Cogn Disord. 2012;33(1):50-8. doi: 10.1159/000335363. Epub 2012 Mar 8. Dement Geriatr Cogn Disord. 2012. PMID: 22415141 Free PMC article.
-
Mitochondrial Pharmacology of Dimebon (Latrepirdine) Calls for a New Look at its Possible Therapeutic Potential in Alzheimer's Disease.Aging Dis. 2018 Aug 1;9(4):729-744. doi: 10.14336/AD.2017.1014. eCollection 2018 Aug. Aging Dis. 2018. PMID: 30090660 Free PMC article. Review.
-
Apple juice improved behavioral but not cognitive symptoms in moderate-to-late stage Alzheimer's disease in an open-label pilot study.Am J Alzheimers Dis Other Demen. 2010 Jun;25(4):367-71. doi: 10.1177/1533317510363470. Epub 2010 Mar 25. Am J Alzheimers Dis Other Demen. 2010. PMID: 20338990 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical